BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
4.3200
19-April-24 12:41:34
15 minutes delayed
Stocks
-0.1800
-4.00%
Today's range
4.3200 - 4.5900
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
19 Apr 2024 10:04:56 By NetDania Notify
-
BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
17 Apr 2024 03:30:39 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
05 Apr 2024 08:45:07 By NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
04 Apr 2024 14:51:53 By NetDania Notify
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
03 Apr 2024 08:45:12 By NetDania Notify
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Apr 2024 06:00:23 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
02 Apr 2024 11:00:22 By NetDania Notify
-
BioCryst to Present at Upcoming Investor Conferences
25 Mar 2024 15:01:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
14 Mar 2024 12:48:51 By NetDania Notify
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Mar 2024 06:01:47 By Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
26 Feb 2024 06:00:05 By Nasdaq GlobeNewswire
-
23 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
21 Feb 2024 15:01:58 By Nasdaq GlobeNewswire
-
BioCryst Launches ORLADEYO® (berotralstat) in Italy
19 Feb 2024 06:54:52 By Nasdaq GlobeNewswire
-
BioCryst to Report Fourth Quarter 2023 Financial Results on February 26
12 Feb 2024 06:00:53 By Nasdaq GlobeNewswire
-
05 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Feb 2024 06:00:48 By Nasdaq GlobeNewswire
-
05 Jan 2024 15:01:00 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Jan 2024 15:01:59 By Nasdaq GlobeNewswire
-
BioCryst to Present at 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 06:00:50 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >